Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Barostat assessment of colorectal sensation and modulation with octreotide in women with irritable bowel syndrome
2007-004994-25Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of octreotide in irritable bowel syndrome (IBS) (2 arms), sponsored by Novartis. Primary endpoint: Colorectal sensory thresholds. Started Oct 2007; status: completed.
02
Drugs
octreotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2007-004994-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004994-25.